查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1699073

灵芝市场成长、规模和趋势分析：按性质和用途 - 区域展望、竞争策略和细分预测（截至 2034 年）

Reishi Mushroom Market Growth, Size, Trends Analysis - By Nature, By Application- Regional Outlook, Competitive Strategies and Segment Forecast to 2034
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 272 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计到 2034 年灵芝市场规模将达到 223.3 亿美元，复合年增长率为 12.29%。

灵芝因其药用特性而受到广泛重视，包括支持免疫系统、抗发炎作用和潜在的抗癌特性。这些好处使得灵芝成为医疗用品中的常见成分。灵芝用于多种药物製剂，包括胶囊、锭剂和萃取物，以提供所需的健康益处。

儘管灵芝越来越受欢迎，但仍存在一些挑战阻碍其市场成长。主要障碍之一是生产成本高，这可能会限制灵芝产品的供应和可负担性，尤其是对于低收入消费者而言。此外，不同供应商的品质差异和污染的可能性可能会引发对产品安全的担忧并削弱消费者信心。

本报告调查了全球灵芝市场，并提供了市场概况摘要、市场影响因素和市场机会分析、市场规模趋势和预测、各个细分市场、地区/主要国家的详细分析、竞争格局以及主要企业的概况。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场动态

  • 驱动因素、阻碍因素、机会与挑战分析

第五章 市场变数与展望

  • SWOT分析
  • PESTEL分析
  • 波特五力分析
  • 热图分析

第六章 竞争格局

  • 製造地、销售区域、产品类型分布
  • 併购、合作伙伴关係、产品发布和合作

7. 灵芝市场按类型

  • 有机的
  • 常规产品

第八章 灵芝市场应用分析

  • 製药
  • 营养补充品
  • 化妆品

第九章 灵芝蘑菇市场

  • 灵芝市场规模与市场占有率

第十章 灵芝市场区域分布

  • 亚太地区
    • 澳洲
    • 中国
    • 印度
    • 日本
    • 韩国
  • 欧洲
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 英国
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • UAE
    • 卡达
    • 南非
    • 埃及
    • 摩洛哥
    • 奈及利亚
    • 其他的
  • 北美洲
    • 加拿大
    • 墨西哥
    • 美国
  • 拉丁美洲
    • 阿根廷
    • 巴西
    • 其他的

第十一章 公司简介

  • Alphay International Inc.
  • Bio-Botanica
  • Bristol Botanicals Limited
  • DXN Holdings Bhd
  • Hokkaido Reishi
  • Hokkaido Reishi Co., Ltd.
  • Mushroom Science
  • Nammex (North American Medicinal Mushroom Extracts)
  • 其他的

第十二章结论

第十三章简称表

第 14 章参考链接

简介目录
Product Code: FOOD2531

Reishi Mushroom Market Introduction and Overview

According to SPER market research, 'Reishi Mushroom Market Size- By Nature, By Application - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Reishi Mushroom Market is predicted to reach 22.33 billion by 2034 with a CAGR of 12.29%.

Reishi mushrooms are widely valued for their medical characteristics, which include immune system support, anti-inflammatory benefits, and potential anti-cancer activity. These advantages make them a common component in therapeutic goods. Reishi mushrooms are used in a variety of medicinal formulations, including capsules, pills, and extracts, in order to deliver targeted health advantages.

Restraints: Despite the growing popularity of reishi mushrooms, several issues are hindering market growth. One major hurdle is the expensive cost of production, which can limit the affordability and availability of reishi-based products, especially for low-income consumers. Furthermore, inconsistencies in quality across suppliers and the likelihood of contamination may cause concerns about product safety, diminishing consumer trust.

Scope of the Report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Nature, By Application.

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.

Companies Covered Alphay International Inc., Bio-Botanica, Bristol Botanicals Limited, DXN Holdings Bhd, Hokkaido Reishi, Hokkaido Reishi Co., Ltd., Mushroom Science, Nammex (North American Medicinal Mushroom Extracts).

Reishi Mushroom Market Segmentation:

By Nature: Based on the Nature, Reishi Mushroom Market is segmented as; Organic, Conventional.

By Application: Based on the Application, Reishi Mushroom Market is segmented as; Pharmaceutical, Dietary Supplements, and Cosmetics.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPERs internal database
    • 2.1.4. Premium insight from KOLs
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTERs Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Reishi Mushroom Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Reishi Mushroom Market

7. Reishi Mushroom Market, By Nature 2021-2034 (USD Million)

  • 7.1. Organic
  • 7.2. Conventional

8. Reishi Mushroom Market, By Application 2021-2034 (USD Million)

  • 8.1. Pharmaceutical
  • 8.2. Dietary Supplements
  • 8.3. Cosmetics

9. Reishi Mushroom Market, 2021-2034 (USD Million)

  • 9.1. Reishi Mushroom Market Size and Market Share

10. Reishi Mushroom Market, By Region, 2021-2034 (USD Million)

  • 10.1. Asia Pacific
    • 10.1.1. Australia
    • 10.1.2. China
    • 10.1.3. India
    • 10.1.4. Japan
    • 10.1.5. South Korea
  • 10.2. Europe
    • 10.2.1. France
    • 10.2.2. Germany
    • 10.2.3. Italy
    • 10.2.4. Spain
    • 10.2.5. United Kingdom
    • 10.2.6. Rest of Europe
  • 10.3. Middle East and Africa
    • 10.3.1. Kingdom of Saudi Arabia
    • 10.3.2. U.A.E
    • 10.3.3. Qatar
    • 10.3.4. South Africa
    • 10.3.5. Egypt
    • 10.3.6. Morocco
    • 10.3.7. Nigeria
    • 10.3.8. Rest of Middle-East and Africa
  • 10.4. North America
    • 10.4.1. Canada
    • 10.4.2. Mexico
    • 10.4.3. United States
  • 10.5. Latin America
    • 10.5.1. Argentina
    • 10.5.2. Brazil
    • 10.5.3. Rest of Latin America

11. Company Profile

  • 11.1. Alphay International Inc.
    • 11.1.1. Company details
    • 11.1.2. Financial outlook
    • 11.1.3. Product summary
    • 11.1.4. Recent developments
  • 11.2. Bio-Botanica
    • 11.2.1. Company details
    • 11.2.2. Financial outlook
    • 11.2.3. Product summary
    • 11.2.4. Recent developments
  • 11.3. Bristol Botanicals Limited
    • 11.3.1. Company details
    • 11.3.2. Financial outlook
    • 11.3.3. Product summary
    • 11.3.4. Recent developments
  • 11.4. DXN Holdings Bhd
    • 11.4.1. Company details
    • 11.4.2. Financial outlook
    • 11.4.3. Product summary
    • 11.4.4. Recent developments
  • 11.5. Hokkaido Reishi
    • 11.5.1. Company details
    • 11.5.2. Financial outlook
    • 11.5.3. Product summary
    • 11.5.4. Recent developments
  • 11.6. Hokkaido Reishi Co., Ltd.
    • 11.6.1. Company details
    • 11.6.2. Financial outlook
    • 11.6.3. Product summary
    • 11.6.4. Recent developments
  • 11.7. Mushroom Science
    • 11.7.1. Company details
    • 11.7.2. Financial outlook
    • 11.7.3. Product summary
    • 11.7.4. Recent developments
  • 11.8. Nammex (North American Medicinal Mushroom Extracts)
    • 11.8.1. Company details
    • 11.8.2. Financial outlook
    • 11.8.3. Product summary
    • 11.8.4. Recent developments
  • 11.9. Others

12. Conclusion

13. List of Abbreviations

14. Reference Links